Stifel Nicolaus Lowers Covetrus (NASDAQ:CVET) Price Target to $18.00

Covetrus (NASDAQ:CVET) had its price target decreased by stock analysts at Stifel Nicolaus from $30.00 to $18.00 in a research note issued on Wednesday, The Fly reports. The firm currently has a “hold” rating on the stock. Stifel Nicolaus’ price objective would indicate a potential upside of 19.05% from the stock’s current price.

Other research analysts also recently issued research reports about the stock. Cleveland Research initiated coverage on shares of Covetrus in a research report on Friday, May 10th. They issued a “hold” rating on the stock. Zacks Investment Research downgraded shares of Covetrus from a “buy” rating to a “hold” rating in a research report on Wednesday, July 17th. ValuEngine downgraded shares of Covetrus from a “buy” rating to a “hold” rating in a research report on Tuesday. Finally, Guggenheim initiated coverage on shares of Covetrus in a research report on Thursday, May 23rd. They issued a “neutral” rating on the stock. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $25.75.

NASDAQ:CVET opened at $15.12 on Wednesday. The firm has a 50-day simple moving average of $23.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.82 and a quick ratio of 0.93. Covetrus has a one year low of $12.22 and a one year high of $43.83.

Covetrus Company Profile

Covetrus, Inc engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.

Recommended Story: How to calculate compound interest

The Fly

Analyst Recommendations for Covetrus (NASDAQ:CVET)

Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.